American Biogenetic Sciences (ABS) files for thrombus precursor clearance
This article was originally published in Clinica
American Biogenetic Sciences has filed its thrombus precursor protein kit for US marketing clearance. The quantitative assay is intended for anticoagulant monitoring and thrombosis risk prediction in a variety of patients. Abbott and Roche both have licences to adapt the test to their immunoanalysers.